Direkt zum Inhalt
Merck
  • Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: the local implication of osteoclasts and macrophages.

Bone tissue formation with human mesenchymal stem cells and biphasic calcium phosphate ceramics: the local implication of osteoclasts and macrophages.

Biomaterials (2014-09-02)
Anne-Laure Gamblin, Meadhbh A Brennan, Audrey Renaud, Hideo Yagita, Frédéric Lézot, Dominique Heymann, Valérie Trichet, Pierre Layrolle
ZUSAMMENFASSUNG

Human mesenchymal stem cells (hMSC) have immunomodulative properties and, associated with calcium phosphate (CaP) ceramics, induce bone tissue repair. However, the mechanisms of osteoinduction by hMSC with CaP are not clearly established, in particular the role of osteoclasts and macrophages. Biphasic calcium phosphate (BCP) particles were implanted with or without hMSC in the paratibial muscles of nude mice. hMSC increased osteoblastic gene expression at 1 week, the presence of macrophages at 2 and 4 weeks, osteoclastogenesis at 4 and 8 weeks, and osteogenesis at 4 and 8 weeks. hMSC disappeared from the implantation site after 2 weeks, indicating that hMSC were inducers rather than effectors of bone formation. Induced blockage of osteoclastogenesis by anti-Rankl treatment significantly impaired bone formation, revealing the pivotal role of osteoclasts in bone formation. In summary, hMSC positively influence the body foreign reaction by attracting circulating haematopoietic stem cells and inducing their differentiation into macrophages M1 and osteoclasts, thus favouring bone formation.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
SSC-Puffer 20×-Konzentrat, for Northern and Southern blotting, solution
Sigma-Aldrich
Proteinase K aus Tritirachium album, lyophilized powder, BioUltra, ≥30 units/mg protein, for molecular biology